Skip to content
Unrated Drug recall · FDA · Published February 12, 2015

Apotex Bromfenac Eye Drops Recalled for CGMP Deviations

Apotex recalls specific lots of Bromfenac Ophthalmic Solution 0.09% due to Good Manufacturing Practice deviations regarding excipient testing.

🇺🇸 FDA recall #D-0487-2015DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Canada
✎ GovInfoNow plain-language explainer

Apotex Inc. is recalling specific lots of Bromfenac Ophthalmic Solution 0.09% because the product's excipient was not re-tested at the appropriate date, constituting a Current Good Manufacturing Practice (CGMP) deviation. The recall affects approximately 33,795 bottles distributed nationwide. The record does not specify what actions consumers should take or if the product poses an immediate health risk. Read more at govinfonow.com/recall/44960-apotex-inc-recalls-bromfenac-ophthalmic-solution-0-09-rx-only.

Source Summary by GovInfoNow · govinfonow.com/recall/44960-apotex-inc-recalls-bromfenac-ophthalmic-solution-0-09-rx-only · Updated October 12, 2026 · FDA enforcement record: FDA #D-0487-2015

Cite this page

“Apotex Bromfenac Eye Drops Recalled for CGMP Deviations.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44960-apotex-inc-recalls-bromfenac-ophthalmic-solution-0-09-rx-only. Based on FDA recall #D-0487-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0487-2015%22&limit=1).

The FDA announced on Feb. 12, 2015, that Apotex Inc. voluntarily recalled Bromfenac Ophthalmic Solution due to CGMP deviations involving untested product excipients, according to the FDA.

How to tell if you have it

  • Brand: Apotex
  • Product: Bromfenac Ophthalmic Solution 0.09%
  • NDC: 60505-0595-5 (1.7 mL Bottle, Lot KY8498, Expiry 01/2016)
  • NDC: 60505-0595-6 (2 x 1.7 mL Bottles, Lot KY8496, Expiry 01/2016)
  • NDC: 60505-0596-4 (2.5 mL Bottles, Lots MC5426 and KZ2002, Expiries 02/2016 and 04/2016)

The hazard

The recall addresses CGMP deviations where the product excipient was not re-tested at the appropriate date, according to the FDA.

Context

GovInfoNow's records show Apotex Inc. has 19 other recalls on record since April 30, 2012. Other recent recalls of similar products include Apotex Metformin Tablets Recall (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall (Oct. 22, 2019), and Apotex Wal-Zan 150mg Tablets Recall (Sept. 24, 2019).

How to tell if you have this one

Check your eye drop bottle for the following details: Brand Apotex; Product Bromfenac Ophthalmic Solution 0.09%; NDC codes 60505-0595-5 (1.7 mL), 60505-0595-6 (2 x 1.7 mL), or 60505-0596-4 (2.5 mL); and Lot numbers KY8498, KY8496, MC5426, or KZ2002 with expiry dates of 01/2016, 02/2016, or 04/2016.

  • Brand
    Apotex
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Feb 12, 201512. FDA classified it Class III: Apr 15, 201523. Published in FDA’s Enforcement Report: Apr 22, 201534. FDA terminated the recall: Dec 30, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0487-2015 (February 12, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0487-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA